#3-17E. Navigating the Diagnostic Maze: Pulmonary Infections in Diffuse Alveolar Hemorrhage (PLoS One, 2025)

How do you distinguish between sterile pulmonary capillaritis and infectious pneumonia when your patient is critically ill with a rheumatic disease? This retrospective, cross-sectional study explores diffuse alveolar hemorrhage (DAH), a life-threatening complication of rheumatic diseases, by investigating the prevalence and risk factors of concurrent pulmonary infections. Analyzing a cohort of 73 patients, the research found that 31.5% of DAH cases were complicated by infections, primarily bacterial and fungal. The most significant discovery is that male sex and the requirement for invasive mechanical ventilation are powerful independent predictors of pulmonary infection, emphasizing the need for heightened vigilance in these high-risk groups. However, when critically appraising this study, we must consider its single-center, retrospective design and limited sample size, which may restrict the generalizability of the findings. For clinicians, this research is vital because the clinical presentations of DAH and infection are nearly identical; thus, early microbiological evaluation via bronchoalveolar lavage is essential to avoid the risks of intensive immunosuppression in the presence of an unrecognized infection.

Citation: Román-Montes CM, Briones-García E, Navarro-Lara SA, Ortiz-Bustamante MA, García-Herrera IP, Guaracha-Basañez GA. Clinical features and pulmonary infections of diffuse alveolar hemorrhage in rheumatic disease patients. PLoS One. 2025. DOI: https://doi.org/10.1371/journal.pone.0339183

Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.